GBAF Logo
Global Banking & Finance Awards® 2026 Nominations open, free to enter Nominate now →
A

Atrium Therapeutics, Inc. Common Stock RNA · USD

Health Care · US listing · 🇺🇸 United States

Compare

8.38

+0.48%

Close of 9 Nov 2026, in USD

Search any instrument

Reference data, closing prices and charts across 45,000 companies, plus crypto, commodities and currencies.

Latest on Atrium Therapeutics, Inc. Common Stock

Our reporting

Next results

12 Nov 2026

Due on 12 Nov 2026. Analysts expect earnings of -0.81 a share on revenue of $15.0m.

Past results

Reported against what analysts expected

13 Aug 202614 May 202626 Feb 202627 Feb 20257 Nov 20249 Aug 2024
Earnings per share-1.18-0.97-0.61-0.80-0.65-0.65
Forecast-1.42-1.05-1.24-0.79-0.71-0.79
Revenue$3.0m$19.6m$2.1m———
Forecast$666,667$2.0m$2.0m$1.6m$4.1m$2.6m

Key events

  1. 28 Jun 2013Listed

Atrium Therapeutics, Inc. Common Stock in the news

Headlines from other publishers, linked to their own pages.

Sources and methodology

Data on this tab
Our reporting and our data supplier
Chart on the Overview
TradingView

Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.